TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency

[1]  B. Gao,et al.  Natural killer and natural killer T cells in liver fibrosis. , 2013, Biochimica et biophysica acta.

[2]  Shelly C. Lu,et al.  Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N‐methyltransferase , 2012, Hepatology.

[3]  G. Karaca,et al.  NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease , 2012, Gut.

[4]  F. Tacke,et al.  Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. , 2011, Gastroenterology.

[5]  L. Galluzzi,et al.  FADD: an endogenous inhibitor of RIP3-driven regulated necrosis , 2011, Cell Research.

[6]  K. Akashi,et al.  Interaction between Toll‐like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis , 2011, Hepatology.

[7]  W. Mehal,et al.  Cell death and fibrogenesis. , 2010, Seminars in liver disease.

[8]  A. Kahraman,et al.  Major histocompatibility complex class I–related chains A and B (MIC A/B): A novel role in nonalcoholic steatohepatitis , 2010, Hepatology.

[9]  C. Trautwein,et al.  Hepatocyte-specific NEMO deletion promotes NK/NKT cell– and TRAIL-dependent liver damage , 2009, The Journal of experimental medicine.

[10]  Joy X Jiang,et al.  Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. , 2009, Journal of hepatology.

[11]  R. Schwabe,et al.  CCR1 and CCR5 promote hepatic fibrosis in mice. , 2009, The Journal of clinical investigation.

[12]  Shelly C. Lu,et al.  S-adenosylmethionine and proliferation: new pathways, new targets. , 2008, Biochemical Society transactions.

[13]  Y. Nakanuma,et al.  Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease , 2008, Proceedings of the National Academy of Sciences.

[14]  G. Gores,et al.  TRAIL mediates liver injury by the innate immune system in the bile duct–ligated mouse , 2008, Hepatology.

[15]  Shelly C. Lu,et al.  Loss of the glycine N‐methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice , 2007, Hepatology.

[16]  D. A. Gomes,et al.  Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll‐like receptor 9 , 2007, Hepatology.

[17]  W. Jeong,et al.  Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[18]  C. Trautwein,et al.  Hepatocyte-Specific IKKγ/NEMO Expression Determines the Degree of Liver Injury , 2007 .

[19]  Chien-Hua Chen,et al.  Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults , 2006, Journal of clinical gastroenterology.

[20]  K. Tsuneyama,et al.  Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. , 2006, Journal of autoimmunity.

[21]  J. Mato,et al.  A Glycine N-methyltransferase Knockout Mouse Model for Humans with Deficiency of this Enzyme , 2006, Transgenic Research.

[22]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[23]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[24]  G. Gores,et al.  Apoptosis: The nexus of liver injury and fibrosis , 2004, Hepatology.

[25]  F. Lammert,et al.  Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. , 2002, Gastroenterology.

[26]  M. Smyth,et al.  Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon γ–Dependent Natural Killer Cell Protection from Tumor Metastasis , 2001, The Journal of experimental medicine.

[27]  Shelly C. Lu,et al.  Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. , 2000, Journal of hepatology.

[28]  C. Trautwein,et al.  Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. , 2007, Gastroenterology.

[29]  R. Schwabe,et al.  TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.

[30]  E. Henson,et al.  Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. , 2002, Apoptosis : an international journal on programmed cell death.

[31]  M. Smyth,et al.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells , 2001, Nature Medicine.